Related Experiment Video

Updated: Mar 13, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

1.0K

miR-204-5p targeting SIRT1 regulates hepatocellular carcinoma progression

Guangbin Jiang1, Li Wen2, Hongmei Zheng3

  • 1Department of Radiology, Suizhou Hospital, Hubei University of Medicine (Suizhou Central Hospital), Hubei, China.

Cell Biochemistry and Function
|October 18, 2016
PubMed

Insights

MicroRNA-204-5p suppresses hepatocellular carcinoma (HCC) progression by inhibiting SIRT1. This finding offers new insights into HCC molecular mechanisms and potential therapeutic targets for this common cancer.

Area of Science:

  • Molecular Oncology
  • Gene Regulation
  • Cancer Biology

Background:

  • Hepatocellular carcinoma (HCC) is a prevalent cancer characterized by aggressive growth, metastasis, and resistance to therapy.
  • MicroRNAs (miRNAs) are implicated in HCC's cellular processes, yet their specific roles and molecular pathways require elucidation.
  • SIRT1 is recognized as a potential oncogene in various cancers, but its interaction with miRNAs in HCC is not fully understood.

Purpose of the Study:

  • To investigate the cellular functions of miR-204-5p in hepatocellular carcinoma (HCC).
  • To elucidate the molecular mechanism underlying miR-204-5p's role in HCC.
  • To determine the relationship between miR-204-5p and SIRT1 in HCC development.

Main Methods:

  • Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) to measure SIRT1 mRNA and miR-204-5p expression.
  • Western blotting to assess SIRT1 protein levels.
  • In vitro assays, including cell proliferation (colony formation) and invasion assays, were conducted.
  • Statistical analysis using SPSS software.

Main Results:

  • SIRT1 was identified as a direct target gene of miR-204-5p.
  • Overexpression of miR-204-5p in HCC cell lines (BEL-7405, QGY-7701) significantly reduced cell survival and proliferation.
  • miR-204-5p overexpression increased apoptosis and enhanced drug sensitivity in HCC cells.
  • SIRT1 was found to be overexpressed in HCC tissues and inversely correlated with miR-204-5p levels.

Conclusions:

  • miR-204-5p acts as a tumor suppressor in hepatocellular carcinoma.
  • The miR-204-5p/SIRT1 axis plays a critical role in the pathogenesis of HCC.
  • These findings highlight miR-204-5p as a potential therapeutic target for HCC treatment.
Keywords:
SIRT1hepatocellular carcinomamiR-204-5p

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K